<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04756908</url>
  </required_header>
  <id_info>
    <org_study_id>CIP-04</org_study_id>
    <nct_id>NCT04756908</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of the Opira AIOL in Comparison to Commercial IOLs in Patients Undergoing Cataract Surgery</brief_title>
  <official_title>Evaluation of the Visual Performance and Safety of the Investigational Opira AIOL, A Commercial Multifocal IOL, and a Commercial Monofocal IOL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FSV6, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FSV6, Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical trial comparing an investigative accommodative IOL and two commercial IOLs&#xD;
      in patients with cataracts undergoing primary cataract surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multicenter clinical study comparing the safety and performance of the&#xD;
      Opira accommodative IOL, a commercial monofocal IOL, and a commercial multifocal IOL.&#xD;
      Eligible patients with bilateral cataracts will undergo cataract surgery implanting one of&#xD;
      three study lenses, and will be followed postoperatively for 24 months&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 8, 2020</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>6 Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse event rates</measure>
    <time_frame>12 Months</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Opira AIOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Monofocal AIOL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Multifocal AIOL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cataract Surgery</intervention_name>
    <description>The surgical procedure in which the natural crystalline lens is removed and replaced with a lens implant.</description>
    <arm_group_label>Monofocal AIOL</arm_group_label>
    <arm_group_label>Multifocal AIOL</arm_group_label>
    <arm_group_label>Opira AIOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female subjects aged 50-75 with bilateral cataracts, good potential vision,&#xD;
             and clear intraocular media other than lens opacity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Comorbidities affecting visual acuity, IOP &gt; 22mmHg, congential cataract&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Paul Rhee, O.D</last_name>
    <phone>9492944191</phone>
    <email>prhee@forsightv6.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinica 2020</name>
      <address>
        <city>San Jos√©</city>
        <country>Costa Rica</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nadja Dodero</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Codet Vision Institute</name>
      <address>
        <city>Tijuana</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martha Federico</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Costa Rica</country>
    <country>Mexico</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2021</study_first_posted>
  <last_update_submitted>February 12, 2021</last_update_submitted>
  <last_update_submitted_qc>February 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

